Wang Chuhui, Zong Xueqing, Wu Fanjie, Leung Ricky Wai Tak, Hu Yaohua, Qin Jing
School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.
College of Professional and Continuing Education, The Hong Kong Polytechnic University, Hong Kong, China.
Front Mol Biosci. 2022 Aug 16;9:920492. doi: 10.3389/fmolb.2022.920492. eCollection 2022.
DNA- and RNA-binding proteins (DRBPs) typically possess multiple functions to bind both DNA and RNA and regulate gene expression from more than one level. They are controllers for post-transcriptional processes, such as splicing, polyadenylation, transportation, translation, and degradation of RNA transcripts in eukaryotic organisms, as well as regulators on the transcriptional level. Although DRBPs are reported to play critical roles in various developmental processes and diseases, it is still unclear how they work with DNAs and RNAs simultaneously and regulate genes at the transcriptional and post-transcriptional levels. To investigate the functional mechanism of DRBPs, we collected data from a variety of databases and literature and identified 118 DRBPs, which function as both transcription factors (TFs) and splicing factors (SFs), thus called DRBP-SF. Extensive investigations were conducted on four DRBP-SFs that were highly expressed in chronic myeloid leukemia (CML), heterogeneous nuclear ribonucleoprotein K (HNRNPK), heterogeneous nuclear ribonucleoprotein L (HNRNPL), non-POU domain-containing octamer-binding protein (NONO), and TAR DNA-binding protein 43 (TARDBP). By integrating and analyzing ChIP-seq, CLIP-seq, RNA-seq, and shRNA-seq data in K562 using binding and expression target analysis and Statistical Utility for RBP Functions, we discovered a two-layer regulatory network system centered on these four DRBP-SFs and proposed three possible regulatory models where DRBP-SFs can connect transcriptional and alternative splicing regulatory networks cooperatively in CML. The exploration of the identified DRBP-SFs provides new ideas for studying DRBP and regulatory networks, holding promise for further mechanistic discoveries of the two-layer gene regulatory system that may play critical roles in the occurrence and development of CML.
DNA和RNA结合蛋白(DRBPs)通常具有多种功能,既能结合DNA和RNA,又能从多个层面调控基因表达。它们是真核生物转录后过程的调控者,如RNA转录本的剪接、聚腺苷酸化、运输、翻译和降解,同时也是转录水平的调控因子。尽管据报道DRBPs在各种发育过程和疾病中发挥着关键作用,但它们如何同时与DNA和RNA相互作用,并在转录和转录后水平调控基因,仍不清楚。为了研究DRBPs的功能机制,我们从各种数据库和文献中收集数据,鉴定出118种DRBPs,它们兼具转录因子(TFs)和剪接因子(SFs)的功能,因此被称为DRBP-SF。我们对在慢性髓性白血病(CML)中高表达的四种DRBP-SF进行了广泛研究,即异质性细胞核核糖核蛋白K(HNRNPK)、异质性细胞核核糖核蛋白L(HNRNPL)、含非POU结构域的八聚体结合蛋白(NONO)和TAR DNA结合蛋白43(TARDBP)。通过使用结合和表达靶点分析以及RBP功能统计工具,整合和分析K562细胞中的ChIP-seq、CLIP-seq、RNA-seq和shRNA-seq数据,我们发现了一个以这四种DRBP-SF为中心的两层调控网络系统,并提出了三种可能的调控模型,其中DRBP-SF可以在CML中协同连接转录和可变剪接调控网络。对鉴定出的DRBP-SF的探索为研究DRBP和调控网络提供了新思路,有望进一步揭示两层基因调控系统的机制,该系统可能在CML的发生和发展中起关键作用。